Kilitch Drugs (India) Limited
Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products
What Kilitch files
- Others45
- Important14
- Board Meeting9
- Dividend/Bonus4
- Updates3
- QIP/Rights/Pref.2
Kilitch Drugs has announced a board meeting to approve the financial results for the quarter and half-year. Q4FY25 standalone PAT surged 212% YoY to Rs 11.37 Cr, with revenue up 44% to Rs 181.59 Cr. Consolidated PAT rose 178% YoY to Rs 10.22 Cr. FY25 standalone PAT grew 77% YoY...
Kilitch Drugs Limited reported impressive financial results for Q3 FY25, showcasing a 222% year-on-year increase in consolidated profit after tax (PAT), reaching Rs. 5.61 crore, up from Rs. 1.74 crore in the same quarter last year. Consolidated revenue from operations surged by 77% to Rs. 56.17 crore, compared to Rs....
Mr. Bhavin Mukund Mehta, Wholetime Director of Kilitch Drugs (India) Limited, has been appointed as the Vice-Chairman of Pharmexcil, the Pharmaceuticals Export Promotion Council of India. With over 25 years in the pharmaceutical sector, Mr. Mehta has been instrumental in expanding Kilitch’s export footprint. His leadership experience includes spearheading the...